MedTrace Logo

Prospective Open Clinical and Genetic Study of Patients With Retinitis Pigmentosa

NCT03901391 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 130

Last updated 2022-05-20

No results posted yet for this study

Summary

This study is aimed to characterize Russian population of Retinitis Pigmentosa

Conditions

Interventions

DIAGNOSTIC_TEST

Whole Exome Sequencing

Whole Exome Sequencing

Sponsors & Collaborators

  • Central Clinical Hospital under President Affairs

    collaborator UNKNOWN

  • Deaf-Blind Support Foundation Con-nection

    collaborator UNKNOWN

  • Federal State Budgetary Institution Moscow Helmholtz Eye Research Institute

    collaborator UNKNOWN

  • Federal State Budgetary Institution Research Center for Medical Genetics

    collaborator UNKNOWN

  • Oftalmic LLC

    collaborator UNKNOWN

  • Center for Genetics and Reproductive Medicine Genetico

    collaborator UNKNOWN

  • Sensor Technology for Deafblind

    lead INDUSTRY

Principal Investigators

  • Dmitry S. Atarshchikov, MD, PhD · Central Clinical Hospital under President Affairs

Eligibility

Min Age
6 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-03-26
Primary Completion
2020-10-19
Completion
2020-10-20

Countries

  • Russia

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03901391 on ClinicalTrials.gov